The oral proteins and peptides market is anticipated to grow at a CAGR of 20%, during 2022-2032, claims Roots Analysis

0 0

The approval of three oral protein / peptide-based therapies has led to a substantial increase in the R&D initiatives being undertaken in this domain, to evaluate the use of such non-invasive therapies for the treatment of a myriad of disease indications The approval of three oral protein / peptide-based therapies has led to a substantial increase in the R&D initiatives being undertaken in this domain, to evaluate the use of such non-invasive therapies for the treatment of a myriad of disease indications

 16 total views,  2 views today

Leave A Reply

Your email address will not be published.